Assessment of Pregnant Women’s Knowledge about Gestational Diabetes at Primary Health Care Centers
Keywords:
Pregnant Women, Gestational Diabetes, Health Care Centers
Abstract
Diabetes mellitus [DM] is a chronic metabolic disease caused by hereditary and/or acquired insufficiency in the production of insulin by the pancreas. The Objective of This Study; To assess the knowledge pregnant women toward Gestational Diabetes at primary health care centers. Methodology: A descriptive statistical study was designed on all pregnant women in primary health care centers in the Karkh region from January 14 to February 14, 2024. Results; Relative to age groups, the highest percentage of study sample is (28.3%) at the age a group (27-30) years, while the lowest percentage is (3.3%) at the age a group (36-40) years and (13.3%) at the age a group (16-20) year and (21.6%) at the age a group (21-26) year and (25%) at the age a group (31-36) and (8.3%) (40 and above) Conclusion; Most of the study sample size has been high of subjects' responses concerned with pregnant women toward gestational diabetes. Recommendation; That continuing education is necessary to improve awareness of GDM.
References
1. Edmonds DK. Dewharts Textbook of Obstetrics and gynecol-ogy. 7th edition. Malden: Blackwell publishers; 2013: 110-112.
2. Alberti, K. G. M. M., Zimmet, P. & Shaw, J. (2006). Metabolic syndrome- new world‐wide definition. A consensus statement from the international diabetes federation. Diabetic Medicine, 23(5), 469-480.
3. A.Malvasi, F. Casciaro, M. M. Minervini et al., “Myo-inositol, D-chiroinositol,
4. folic acid and manganese in second trimester of preg-nancy: a preliminary investigation,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 2, pp. 270–274, 2014.
5. Byrn, M.; Penckofer, S. The relationship between gestational diabetes and antenatal depression. J. Obstet. Gynecol. Neonatal Nurs. 2015, 44, 246–255.
6. Capula, C.; Chiefari, E.; Vero, A.; Arcidiacono, B.; Iiritano, S.; Puccio, L.; Pullano, V.; Foti, D.P.; Brunetti, A.; Vero, R. Gesta-tional Diabetes Mellitus: Screening and Outcomes in Southern Ital-ian Pregnant Women. Available online:
7. https://www.hindawi.com/journals/isrn/2013/387495/ (accessed on 9 October 2018).
8. De Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose moni-toring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237–41.
9. Egan, A.M.; Vellinga, A.; Harreiter, J.; Simmons, D.; Desoye, G.; Corcoy, R.; Adelantado, J.M.; Devlieger, R.; Assche, A.V.; Galjaard, S.; et al. Epidemiology of
gestational diabetes mellitus ac-cording to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia 2017, 1–9.
10. F. Corrado, R. D’Anna, A. S. Laganà, and A. Di Benedetto, “Abnormal glucose tolerance later in life in women affected by glu-cose intolerance during pregnancy,” Journal of Obstetrics and Gy-naecology, vol. 34, no. 2, pp. 123–126, 2014.
11. Friedman, J.E.; Kirwan, J.P.; Jing, M.; Presley, L.; Catalano, P.M. Increased Skeletal Muscle Tumor Necrosis Factor-α and Im-paired Insulin Signaling Persist in Obese Women with Gestational Diabetes Mellitus 1 Year Postpartum. Diabetes 2008, 57, 606–613.
12. Giorgino, F.; Laviola, L.; Eriksson, J.W. Regional differences of insulin action in adipose tissue: Insights from in vivo and in vitro studies. Acta Physiol. Scand. 2005, 183, 13–30.
13. Haneda, M.; Noda, M.; Origasa, H.; Noto, H.; Yabe, D.; Fu-jita, Y.; Goto, A.; Kondo, T.; Araki, E. Japanese Clinical Practice Guideline for Diabetes 2016. J. Diabetes Investig. 2018, 9, 657–697
14. Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, et al. Metabolic and immunologic effects of insulin lispro in ges-tational diabetes. Diabetes Care. 1999;22:1422–7.
15. L. Costabile and V. Unfer, “Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from peculiar case,” European Review for Medical and Pharmacological Sciences, vol. 21, Supplement 2, pp. 73–76, 2017.
16. M. L. Croze and C. O. Soulage, “Potential role and therapeutic interests of myo-inositol in metabolic diseases,” Biochemie, vol. 95, no. 10, pp. 1811–1827, 2013.
17. World health organization (2016). Global report on diabetes. Retrieved from 10665/204871/1/9789241565257_eng.pdf M. L. Croze and C. O. Soulage, “Potential role and therapeutic interests of myo-inositol in metabolic diseases,” Biochemie, vol. 95, no. 10, pp. 1811–1827, 2013.
18. Oxford dictionary (American English) (US)". oxforddictionar-ies.com. Archived from the original on 14 July 2010.
19. Pintaudi, G. Di Vieste, and M. Bonomo, “The effectiveness of myoinositol and D-chiro inositol treatment in type 2 diabetes,” In-ternational Journal of Endocrinology, vol. 2016, Article ID 9132052, 5 pages, 2016.
20. R. Coustan, “Can a dietary supplement prevent gestational di-abetes mellitus?” Diabetes Care, vol. 36, no. 4, pp. 777–779, 2013.
21. 19.Tam, W.H.; Ma, R.C.W.; Ozaki, R.; Li, A.M.; Chan, M.H.M.; Yuen, L.Y.; Lao, T.T.H.; Yang, X.; Ho, C.S.; Tutino, G.E.; et al. In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring. Diabetes Care 2017, 40, 679–686.
22. V. Unfer, G. Carlomagno, G. Dante, and F. Facchinetti, “Ef-fects o myo inositol in women with PCOS: a systematic review of randomized controlled trials,” Gynecological Endocrinology, vol. 28, no. 7, pp. 509– 515, 2012.
23. World Health Organization (WHO). Global Action Plan for the Prevention and Control of NCDs 2013–2020; WHO: Geneva, Switzerland, 2013.
24. X. Zheng, Z. Liu, Y. Zhang et al., “Relationship between myo-inositol supplementary and gestational diabetes mellitus: a meta-analysis,” Medicine, vol. 94, no.
42, article e1604, 2015.
25. Zajdenverg, L.; Negrato, C.A. Gestational diabetes mellitus and type 2 diabetes: Same disease in a different moment of life? Maybe not. Arch. Endocrinol. MeTable 2017, 61, 208–210.
2. Alberti, K. G. M. M., Zimmet, P. & Shaw, J. (2006). Metabolic syndrome- new world‐wide definition. A consensus statement from the international diabetes federation. Diabetic Medicine, 23(5), 469-480.
3. A.Malvasi, F. Casciaro, M. M. Minervini et al., “Myo-inositol, D-chiroinositol,
4. folic acid and manganese in second trimester of preg-nancy: a preliminary investigation,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 2, pp. 270–274, 2014.
5. Byrn, M.; Penckofer, S. The relationship between gestational diabetes and antenatal depression. J. Obstet. Gynecol. Neonatal Nurs. 2015, 44, 246–255.
6. Capula, C.; Chiefari, E.; Vero, A.; Arcidiacono, B.; Iiritano, S.; Puccio, L.; Pullano, V.; Foti, D.P.; Brunetti, A.; Vero, R. Gesta-tional Diabetes Mellitus: Screening and Outcomes in Southern Ital-ian Pregnant Women. Available online:
7. https://www.hindawi.com/journals/isrn/2013/387495/ (accessed on 9 October 2018).
8. De Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose moni-toring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237–41.
9. Egan, A.M.; Vellinga, A.; Harreiter, J.; Simmons, D.; Desoye, G.; Corcoy, R.; Adelantado, J.M.; Devlieger, R.; Assche, A.V.; Galjaard, S.; et al. Epidemiology of
gestational diabetes mellitus ac-cording to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia 2017, 1–9.
10. F. Corrado, R. D’Anna, A. S. Laganà, and A. Di Benedetto, “Abnormal glucose tolerance later in life in women affected by glu-cose intolerance during pregnancy,” Journal of Obstetrics and Gy-naecology, vol. 34, no. 2, pp. 123–126, 2014.
11. Friedman, J.E.; Kirwan, J.P.; Jing, M.; Presley, L.; Catalano, P.M. Increased Skeletal Muscle Tumor Necrosis Factor-α and Im-paired Insulin Signaling Persist in Obese Women with Gestational Diabetes Mellitus 1 Year Postpartum. Diabetes 2008, 57, 606–613.
12. Giorgino, F.; Laviola, L.; Eriksson, J.W. Regional differences of insulin action in adipose tissue: Insights from in vivo and in vitro studies. Acta Physiol. Scand. 2005, 183, 13–30.
13. Haneda, M.; Noda, M.; Origasa, H.; Noto, H.; Yabe, D.; Fu-jita, Y.; Goto, A.; Kondo, T.; Araki, E. Japanese Clinical Practice Guideline for Diabetes 2016. J. Diabetes Investig. 2018, 9, 657–697
14. Jovanovic L, Ilic S, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, et al. Metabolic and immunologic effects of insulin lispro in ges-tational diabetes. Diabetes Care. 1999;22:1422–7.
15. L. Costabile and V. Unfer, “Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from peculiar case,” European Review for Medical and Pharmacological Sciences, vol. 21, Supplement 2, pp. 73–76, 2017.
16. M. L. Croze and C. O. Soulage, “Potential role and therapeutic interests of myo-inositol in metabolic diseases,” Biochemie, vol. 95, no. 10, pp. 1811–1827, 2013.
17. World health organization (2016). Global report on diabetes. Retrieved from 10665/204871/1/9789241565257_eng.pdf M. L. Croze and C. O. Soulage, “Potential role and therapeutic interests of myo-inositol in metabolic diseases,” Biochemie, vol. 95, no. 10, pp. 1811–1827, 2013.
18. Oxford dictionary (American English) (US)". oxforddictionar-ies.com. Archived from the original on 14 July 2010.
19. Pintaudi, G. Di Vieste, and M. Bonomo, “The effectiveness of myoinositol and D-chiro inositol treatment in type 2 diabetes,” In-ternational Journal of Endocrinology, vol. 2016, Article ID 9132052, 5 pages, 2016.
20. R. Coustan, “Can a dietary supplement prevent gestational di-abetes mellitus?” Diabetes Care, vol. 36, no. 4, pp. 777–779, 2013.
21. 19.Tam, W.H.; Ma, R.C.W.; Ozaki, R.; Li, A.M.; Chan, M.H.M.; Yuen, L.Y.; Lao, T.T.H.; Yang, X.; Ho, C.S.; Tutino, G.E.; et al. In Utero Exposure to Maternal Hyperglycemia Increases Childhood Cardiometabolic Risk in Offspring. Diabetes Care 2017, 40, 679–686.
22. V. Unfer, G. Carlomagno, G. Dante, and F. Facchinetti, “Ef-fects o myo inositol in women with PCOS: a systematic review of randomized controlled trials,” Gynecological Endocrinology, vol. 28, no. 7, pp. 509– 515, 2012.
23. World Health Organization (WHO). Global Action Plan for the Prevention and Control of NCDs 2013–2020; WHO: Geneva, Switzerland, 2013.
24. X. Zheng, Z. Liu, Y. Zhang et al., “Relationship between myo-inositol supplementary and gestational diabetes mellitus: a meta-analysis,” Medicine, vol. 94, no.
42, article e1604, 2015.
25. Zajdenverg, L.; Negrato, C.A. Gestational diabetes mellitus and type 2 diabetes: Same disease in a different moment of life? Maybe not. Arch. Endocrinol. MeTable 2017, 61, 208–210.
Published
2024-07-22
How to Cite
Hwaidi, E. H., & Yousif, A. Y. (2024). Assessment of Pregnant Women’s Knowledge about Gestational Diabetes at Primary Health Care Centers. Central Asian Journal of Medical and Natural Science, 5(3), 854-858. Retrieved from https://www.cajmns.centralasianstudies.org/index.php/CAJMNS/article/view/2528
Section
Articles
